Welcome to our dedicated page for Cineverse SEC filings (Ticker: CNVS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cineverse Corp.’s streaming empire spans horror hits, anime cult classics, and FAST channels that beam Bob Ross to global TVs. That diversity makes its SEC paperwork dense with revenue mix tables, content-library amortisation schedules, and technology R&D footnotes. If you have ever searched "Cineverse SEC filings explained simply" you already know the challenge: hundreds of pages, dozens of exhibits, and fast-moving disclosure of new licensing deals.
Stock Titan solves that problem. Our AI reads every Cineverse annual report 10-K simplified, flags how SVOD vs AVOD sales shift, and summarises goodwill tests in plain English. The moment a Cineverse quarterly earnings report 10-Q filing or Cineverse 8-K material events explained hits EDGAR, you receive real-time access plus an AI-powered synopsis that highlights segment margins and subscriber growth. Need transaction details? The platform pulls Cineverse insider trading Form 4 transactions and pushes Cineverse Form 4 insider transactions real-time alerts so you can see when executives buy shares after a blockbuster premiere.
Investors, analysts, and content partners use these filings to:
- Track Matchpoint™ SaaS revenue acceleration inside the 10-K
- Compare cash burn to catalogue amortisation across quarters with one-click Cineverse earnings report filing analysis
- Review Cineverse proxy statement executive compensation to see bonuses tied to FAST channel viewership
- Monitor Cineverse executive stock transactions Form 4 alongside upcoming horror releases
Whether you’re understanding Cineverse SEC documents with AI for the first time or fine-tuning a valuation model, Stock Titan’s intelligent summaries, side-by-side comparisons, and historical archive put every disclosure in context—without wading through jargon.
Cineverse Corp. (CNVS) filed definitive additional proxy materials tied to its 2025 annual meeting set for November 20, 2025. The filing states it was made solely to include required interactive data; all other proxy details remain unchanged.
Stockholders will vote on electing four directors, an advisory say‑on‑pay, the frequency of future say‑on‑pay (the Board recommends 1 year), an amendment to the 2017 Equity Incentive Plan to increase authorized shares from 2,504,913 to 3,504,913, and ratification of EisnerAmper LLP as auditor for the year ending March 31, 2026.
Holders of record on September 24, 2025 may vote. 19,124,406 shares of Class A Common Stock were outstanding as of that date. The proxy outlines plan governance features (no evergreen, no repricing without stockholder approval, minimum one‑year vesting, clawback) and indicates non‑employee director equity awards valued at $90,000 annually (based on 20‑day VWAP) and $180,000 for new directors. CNVS last closed at $3.50 on September 24, 2025.
Mark W. Lindsey, Chief Financial Officer of Cineverse Corp. (CNVS) reported changes in his holdings on
The disclosure itemizes vesting timelines: portions of RSUs vest in
Insider transfer reported by Cineverse Corp. officer Yolanda Macias. The filing shows Ms. Macias holds 93,949 Class A shares indirectly and reports a disposition of 93,949 Class A shares plus an indirect 146 share holding for a minor child. She also holds multiple equity awards: two stock appreciation rights covering 30,000 and 25,000 shares with exercise prices of
Christopher J. McGurk, CEO and Chairman of Cineverse Corp. (CNVS), reported changes in his beneficial ownership on
Insider transaction summary for Cineverse Corp. (CNVS): The reporting officer, Mark Antonio Huidor, reported a disposal and several derivative/award holdings. On
Cineverse Corp. (CNVS) reported an insider equity award on a Form 4. The company’s Chief People Officer received 66,763 restricted stock units (RSUs) on 10/08/2025 (transaction code A, price $0). These RSUs vest in three equal-year tranches: 22,254 on October 8, 2026, 22,254 on October 8, 2027, and 22,255 on October 8, 2028.
Following the reported transactions, the officer beneficially owned 158,274 shares of Class A common stock directly. Derivative holdings include stock appreciation rights for 8,334 shares (exercise price $39.4, expiring 02/17/2031) and 12,500 shares (exercise price $5.8, expiring 05/16/2033), plus other RSUs of 66,667 and 76,820 with stated vesting schedules.
Erick Opeka, CSO and President of Cineverse Corp. (CNVS), reported multiple equity changes on
Gary S. Loffredo, Chief Legal Officer, Secretary and Senior Advisor at Cineverse Corp. (CNVS), filed a Form 4 reporting multiple equity changes on
Cineverse Corp. outlines its 2017 Equity Incentive Plan governance and 2023–2025 executive and director compensation practices. The plan is administered by an independent Compensation Committee, has no evergreen replenishment, and caps aggregate director awards at 300,000 shares. Awards generally carry a minimum one-year vesting requirement (with a 5% exception), prohibit discounted options or repricings without stockholder approval, and are subject to the company's clawback policy.
Reported grants include 237,500 restricted stock awards and 237,500 restricted stock units to NEOs in fiscal 2025 (accounting for $1,501,000 of NEO CAP), and 150,000 restricted awards and 150,000 restricted units to the PEO in fiscal 2025 (accounting for $948,000 of the PEO CAP). Prior-year grants included 115,000 options in 2024 and 125,000 options in 2023 with multi-year vesting and ten-year option terms where noted. Non-employee director pay includes a $60,000 cash retainer, a $90,000 annual stock grant (trailing 20-day VWAP), committee fees, a $20,000 lead director fee, and a $180,000 new-director grant vesting over three years.
FAQ
What is the current stock price of Cineverse (CNVS)?
What is the market cap of Cineverse (CNVS)?
